ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $211,000 | -72.5% | 6,391 | -61.7% | 0.03% | -51.5% |
| Q1 2022 | $767,000 | +127.6% | 16,684 | +228.0% | 0.07% | +153.8% |
| Q4 2021 | $337,000 | -69.3% | 5,087 | -71.0% | 0.03% | -67.1% |
| Q3 2021 | $1,096,000 | +49.5% | 17,554 | +98.3% | 0.08% | +64.6% |
| Q2 2021 | $733,000 | +218.7% | 8,854 | +65.7% | 0.05% | +220.0% |
| Q3 2020 | $230,000 | -83.8% | 5,344 | -94.9% | 0.02% | -72.2% |
| Q2 2018 | $1,421,000 | -57.1% | 104,500 | -77.3% | 0.05% | -51.8% |
| Q1 2018 | $3,312,000 | +168.4% | 459,400 | +37.1% | 0.11% | +211.1% |
| Q4 2017 | $1,234,000 | – | 335,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |